Natural Product Sciences

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지
DOI QR코드

DOI QR Code

Anti-nociceptive and Anti-inflammatory Properties of Ilex latifolia and its Active Component, 3,5-Di-caffeoyl Quinic Acid Methyl Ester

  • Kim, Joo Youn (College of Veterinary Medicine, Chungbuk National University) ;
  • Lee, Hong Kyu (College of Veterinary Medicine, Chungbuk National University) ;
  • Seong, Yeon Hee (College of Veterinary Medicine, Chungbuk National University)
  • Received : 2018.07.31
  • Accepted : 2018.11.29
  • Published : 2019.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

The present study was conducted to investigate anti-nociceptive and anti-inflammatory effects of the leaves of Ilex latifolia Thunb (I. latifolia) in in vivo and in vitro. Writhing responses induced by acetic acid and formalin- and thermal stimuli (tail flick and hot plate tests)-induced pain responses for nociception were evaluated in mice. I. latifolia (50 - 200 mg/kg, p.o.) and ibuprofen (100 mg/kg, p.o.), a positive non-steroidal anti-inflammatory drug (NSAID), inhibited the acetic acid-induced writhing response and the second phase response (peripheral inflammatory response) in the formalin test, but did not protect against thermal nociception and the first phase response (central response) in the formalin test. These results show that I. latifolia has a significant anti-nociceptive effect that appears to be peripheral, but not central. Additionally, I. latifolia (50 and $100{\mu}g/mL$) and 3,5-di-caffeoyl quinic acid methyl ester ($5{\mu}M$) isolated from I. latifolia as an active compound significantly inhibited LPS-induced NO production and mRNA expression of the pro-inflammatory mediators, iNOS and COX-2, and the pro-inflammatory cytokines, IL-6 and $IL-1{\beta}$, in RAW 264.7 macrophages. These results suggest that I. latifolia can produce antinociceptive effects peripherally, but not centrally, via anti-inflammatory activity and supports a possible use of I. latifolia to treat pain and inflammation.

Keywords

References

  1. Behrens, M. M.; Strasser, U.; Koh, J. Y.; Gwag, B. J.; Choi, D. W. Neuroscience 1999, 94, 917-927. https://doi.org/10.1016/S0306-4522(99)00212-2
  2. Needleman, P.; Isakson, P. C. J. Rheumatol. Suppl. 1997, 49, 6-8.
  3. Mense, S. Brain Res. 1981, 225, 95-105. https://doi.org/10.1016/0006-8993(81)90320-6
  4. Prescott, S. M.; Yost, H. J. Proc. Natl. Acad. Sci. U S A 2002, 99, 9084-9086. https://doi.org/10.1073/pnas.152280699
  5. Crofford, L. J.; Lipsky, P. E.; Brooks, P.; Abramson, S. B.; Simon, L. S.; van de Putte, L. B. Arthritis Rheum. 2000, 43, 4-13. https://doi.org/10.1002/1529-0131(200001)43:1<4::AID-ANR2>3.0.CO;2-V
  6. Seybold, V. S.; Jia, Y. P.; Abrahams, L. G. Pain 2003, 105, 47-55. https://doi.org/10.1016/S0304-3959(03)00254-9
  7. Szabo, C.; Thiemermann, C.; Wu, C. C.; Perretti, M.; Vane, J. R. Proc. Natl. Acad. Sci. U S A 1994, 91, 271-275. https://doi.org/10.1073/pnas.91.1.271
  8. Kleinert, H.; Pautz, A.; Linker, K.; Schwarz, P. M. Eur. J. Pharmacol. 2004, 500, 255-266. https://doi.org/10.1016/j.ejphar.2004.07.030
  9. Clancy, R. M.; Amin, A. R.; Abramson, S. B. Arthritis Rheum. 1998, 41, 1141-1151. https://doi.org/10.1002/1529-0131(199807)41:7<1141::AID-ART2>3.0.CO;2-S
  10. Walsh, L. J. Crit. Rev. Oral Biol. Med. 2003, 14, 188-198. https://doi.org/10.1177/154411130301400304
  11. Sung, C. S.; Wong, C. S. Acta Anaesthesiol. Taiwan. 2007, 45, 103-109.
  12. Lawrence, T.; Willoughby, D. A.; Gilroy, D. W. Nat. Rev. Immunol. 2002, 2, 787-795. https://doi.org/10.1038/nri915
  13. Fan, J.; Wu, Z.; Zhao, T.; Sun, Y.; Ye, H.; Xu, R.; Zeng, X. Carbohydr. Polym. 2014, 101, 990-997. https://doi.org/10.1016/j.carbpol.2013.10.037
  14. Kim, J. Y.; Jeong, H. Y.; Lee, H. K.; Yoo, J. K.; Bae, K.; Seong, Y. H. J. Ethnopharmacol. 2011, 133, 558-564. https://doi.org/10.1016/j.jep.2010.10.037
  15. Kim, J. Y.; Lee, H. K.; Hwang, B. Y.; Kim, S.; Yoo, J. K.; Seong, Y. H. Arch. Pharm. Res. 2012, 35, 1115-1122. https://doi.org/10.1007/s12272-012-0620-y
  16. Negishi, O.; Negishi, Y.; Yamaguchi, F.; Sugahara, T. J. Agric. Food Chem. 2004, 52, 5513-5518. https://doi.org/10.1021/jf049693j
  17. Li, L.; Xu, L. J.; Ma, G. Z.; Dong, Y. M.; Peng, Y.; Xiao, P. G. J. Nat. Med. 2013, 67, 425-437. https://doi.org/10.1007/s11418-013-0758-z
  18. Hu, T.; He, X. W.; Jiang, J. G. J. Agric. Food Chem. 2014, 62, 8608-8615. https://doi.org/10.1021/jf501670v
  19. Kim, J. Y.; Lee, H. K.; Jang, J. Y.; Yoo, J. K.; Seong, Y. H. J. Med. Food 2015, 18, 1317-1326. https://doi.org/10.1089/jmf.2015.3443
  20. Matheus, M. E.; Berrondo, L. F.; Vieitas, E. C.; Menezes, F. S.; Fernandes, P. D. J. Ethnopharmacol. 2005, 102, 377-381. https://doi.org/10.1016/j.jep.2005.06.033
  21. Gomes, N. M.; Rezende, C. M.; Fontes, S. P.; Matheus, M. E.; Fernandes, P. D. J. Ethnopharmacol. 2007, 109, 486-492. https://doi.org/10.1016/j.jep.2006.08.018
  22. Eddy, N. B.; Leimbach, D. J. Pharmacol. Exp. Ther. 1953, 107, 385-393.
  23. D'Amour, F. E.; Smith, D. L. J. Pharmacol. Exp. Ther. 1941, 72, 74-79.
  24. Cho, W.; Nam, J. W.; Kang, H. J.; Windono, T.; Seo, E. K.; Lee, K. T. Int. Immunopharmacol. 2009, 9, 1049-1057. https://doi.org/10.1016/j.intimp.2009.04.012
  25. Lee, M. A.; Lee, H. K.; Kim, S. H.; Kim, Y. C.; Sung, S. H. Planta Med. 2010, 76, 1007-1010. https://doi.org/10.1055/s-0029-1240911
  26. Vinegar, R.; Truax, J. F.; Selph, J. L.; Johnston, P. R. In Anti-inflammatory Drugs; Vane, J. R.; Ferreira, S. H. Eds. Springer; Germany, 1979, pp 208-222.
  27. de Oliveira, A. M.; de Araujo, A. F.; Lyra Lemos, R. P.; Conserva, L. M.; de Souza Ferro, J. N.; Barreto, E. J. Nat. Med. 2015, 69, 232-240. https://doi.org/10.1007/s11418-014-0883-3
  28. Zhao, C. S.; Tao, Y. X.; Tall, J. M.; Donovan, D. M.; Meyer, R. A.; Raja, S. N. Exp. Neurol. 2003, 184, 839-845. https://doi.org/10.1016/S0014-4886(03)00346-7
  29. Puig, S.; Sorkin, L. S. Pain 1996, 64, 345-355. https://doi.org/10.1016/0304-3959(95)00121-2
  30. Hunskaar, S.; Hole, K. Pain 1987, 30, 103-114. https://doi.org/10.1016/0304-3959(87)90088-1
  31. Malmberg, A. B.; Yaksh, T. L. J. Pharmacol. Exp. Ther. 1992, 263, 136-146.
  32. Sevostianova, N.; Zvartau, E.; Bespalov, A.; Danysz, W. Eur. J. Pharmacol. 2003, 462, 109-113. https://doi.org/10.1016/S0014-2999(03)01345-1
  33. Walker, K.; Fox, A. J.; Urban, L. A. Mol. Med. Today 1999, 5, 319-321. https://doi.org/10.1016/S1357-4310(99)01493-8
  34. Sweet, M. J.; Hume, D. A. J. Leukoc. Biol. 1996, 60, 8-26. https://doi.org/10.1002/jlb.60.1.8
  35. Bosca, L.; Zeini, M.; Traves, P. G.; Hortelano, S. Toxicology 2005, 208, 249-258. https://doi.org/10.1016/j.tox.2004.11.035
  36. Saravanan, R.; Viswanathan, P.; Pugalendi, K. V. Life Sci. 2006, 78, 713-718. https://doi.org/10.1016/j.lfs.2005.05.060
  37. Albina, J. E.; Reichner, J. S. New Horiz. 1995, 3, 46-64.
  38. Barnes, P. J.; Liew, F. Y. Immunol. Today 1995, 16, 128-130. https://doi.org/10.1016/0167-5699(95)80128-6
  39. Anderson, G. D.; Hauser, S. D.; McGarity, K. L.; Bremer, M. E.; Isakson, P. C.; Gregory, S. A. J. Clin. Invest. 1996, 97, 2672-2679. https://doi.org/10.1172/JCI118717
  40. Kuwano, T.; Nakao, S.; Yamamoto, H.; Tsuneyoshi, M.; Yamamoto, T.; Kuwano, M.; Ono, M. FASEB J. 2004, 18, 300-310. https://doi.org/10.1096/fj.03-0473com
  41. Zychlinsky, A.; Fitting, C.; Cavaillon, J. M.; Sansonetti, P. J. J. Clin. Invest. 1994, 94, 1328-1332. https://doi.org/10.1172/JCI117452

Cited by

  1. Chemical Structure and Biological Activities of Secondary Metabolites from Salicornia europaea L. vol.26, pp.8, 2019, https://doi.org/10.3390/molecules26082252
  2. Phytochemical and Biological Screening of Leaf, Bark and Fruit Extracts from Ilex dipyrena Wall. vol.11, pp.8, 2021, https://doi.org/10.3390/life11080837
  3. Evaluation of antinociceptive activity of Ilex dipyrena Wall. in mice vol.21, pp.1, 2019, https://doi.org/10.1186/s12906-021-03357-4